company background image
A397030 logo

AprilBioLtd KOSDAQ:A397030 Stock Report

Last Price

₩14.11k

Market Cap

₩306.5b

7D

-9.1%

1Y

13.8%

Updated

15 Jun, 2024

Data

Company Financials +

AprilBio Co.,Ltd.

KOSDAQ:A397030 Stock Report

Market Cap: ₩306.5b

A397030 Stock Overview

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.

A397030 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

AprilBio Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for AprilBioLtd
Historical stock prices
Current Share Price₩14,110.00
52 Week High₩19,150.00
52 Week Low₩9,115.00
Beta0
1 Month Change-9.14%
3 Month Change-17.24%
1 Year Change13.79%
3 Year Changen/a
5 Year Changen/a
Change since IPO29.15%

Recent News & Updates

Recent updates

Shareholder Returns

A397030KR BiotechsKR Market
7D-9.1%-3.1%1.1%
1Y13.8%12.6%3.7%

Return vs Industry: A397030 exceeded the KR Biotechs industry which returned 12.6% over the past year.

Return vs Market: A397030 exceeded the KR Market which returned 3.7% over the past year.

Price Volatility

Is A397030's price volatile compared to industry and market?
A397030 volatility
A397030 Average Weekly Movement7.7%
Biotechs Industry Average Movement7.7%
Market Average Movement5.0%
10% most volatile stocks in KR Market11.2%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A397030's share price has been volatile over the past 3 months.

Volatility Over Time: A397030's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
2013n/aSang-Hoon Chawww.aprilbio.com

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases.

AprilBio Co.,Ltd. Fundamentals Summary

How do AprilBioLtd's earnings and revenue compare to its market cap?
A397030 fundamental statistics
Market cap₩306.49b
Earnings (TTM)₩0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A397030 income statement (TTM)
Revenue₩0
Cost of Revenue₩0
Gross Profit₩0
Other Expenses₩0
Earnings₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did A397030 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.